We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+11.43%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$43.4B
AUM Growth
+$3.14B
(+7.8%)
Cap. Flow
-$115M
Cap. Flow
% of AUM
-0.27%
Top 10 Holdings %
Top 10 Hldgs %
13.22%
Holding
2,192
New
164
Increased
795
Reduced
936
Closed
172
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$193M |
| 2 |
Gilead Sciences
GILD
|
+$115M |
| 3 |
Tencent Music
TME
|
+$83.5M |
| 4 |
Kanzhun
BZ
|
+$76.7M |
| 5 |
Wheaton Precious Metals
WPM
|
+$68.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$189M |
| 2 |
Williams Companies
WMB
|
+$155M |
| 3 |
AYX
Alteryx Inc
AYX
|
+$94.1M |
| 4 |
AbbVie
ABBV
|
+$87M |
| 5 |
Amgen
AMGN
|
+$78.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.44% |
| 2 | Healthcare | 17.1% |
| 3 | Financials | 12.78% |
| 4 | Industrials | 10.38% |
| 5 | Consumer Discretionary | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Union Pacific
UNP
$167B
| $762K | ﹤0.01% |
3,098
-34,324
| -92% | -$8.45M |
|
1227
SEI Investments
SEIC
$12.6B
| $762K | ﹤0.01% |
10,595
-667
| -6% | -$44.3K |
|
1228
Lithia Motors
LAD
$7.46B
| $761K | ﹤0.01% |
2,529
-215
| -8% | -$63.6K |
|
1229
Kyndryl
KD
$2.8B
| $760K | ﹤0.01% |
34,943
+1,611
| +5% | +$34.3K |
|
1230
Mine Safety
MSA
$6.94B
| $760K | ﹤0.01% |
3,925
-235
| -6% | -$41.3K |
|
|
ETRN
1231
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $758K | ﹤0.01% |
60,719
-489,138
| -89% | -$5.25M |
|
1232
A10 Networks
ATEN
$1.93B
| $756K | ﹤0.01% |
55,209
| – | – |
|
1233
Brixmor Property Group
BRX
$8.59B
| $748K | ﹤0.01% |
31,897
-9,254
| -22% | -$210K |
|
1234
Zions Bancorporation
ZION
$9.56B
| $742K | ﹤0.01% |
17,090
+16,445
| +2,550% | +$678K |
|
|
VISN
1235
Vistance Networks Inc
VISN
$1.5B
| $741K | ﹤0.01% |
565,413
+183,628
| +48% | +$362K |
|
1236
Thor Industries
THO
$3.63B
| $741K | ﹤0.01% |
6,312
-13,004
| -67% | -$1.49M |
|
1237
Welltower
WELL
$169B
| $735K | ﹤0.01% |
7,867
-1,379
| -15% | -$125K |
|
1238
NextCure
NXTC
$27.6M
| $730K | ﹤0.01% |
27,284
-37
| -0.1% | -$637 |
|
|
YMAB
1239
DELISTED
Y-mAbs Therapeutics
YMAB
| $725K | ﹤0.01% |
44,565
+91
| +0.2% | +$1.23K |
|
1240
United Bankshares
UBSI
$6.44B
| $719K | ﹤0.01% |
20,085
-39,421
| -66% | -$1.39M |
|
1241
Newell Brands
NWL
$2.42B
| $718K | ﹤0.01% |
89,471
-1,040
| -1% | -$8.28K |
|
1242
ASE Group
ASX
$98.8B
| $715K | ﹤0.01% |
65,095
-8,085
| -11% | -$79.3K |
|
1243
Globus Medical
GMED
$10.1B
| $713K | ﹤0.01% |
13,300
-1,087
| -8% | -$58.4K |
|
1244
First American
FAF
$7.26B
| $712K | ﹤0.01% |
11,658
+1,825
| +19% | +$108K |
|
1245
Horizon Bancorp
HBNC
$1B
| $712K | ﹤0.01% |
55,461
+29,741
| +116% | +$379K |
|
1246
Evercore
EVR
$10.1B
| $708K | ﹤0.01% |
3,677
-209
| -5% | -$37.8K |
|
1247
Hexcel
HXL
$6.89B
| $706K | ﹤0.01% |
9,698
-220
| -2% | -$15.8K |
|
1248
Crane Co
CR
$11.4B
| $699K | ﹤0.01% |
5,174
-286
| -5% | -$35.2K |
|
1249
NOV
NOV
$7.33B
| $699K | ﹤0.01% |
35,790
-8,947
| -20% | -$166K |
|
|
EFOR
1250
Everforth Inc
EFOR
$1.33B
| $698K | ﹤0.01% |
6,661
-659
| -9% | -$63.7K |
|
Similar funds
Federated Hermes's Q1 2024 Portfolio in Review
As of Q1 2024, Federated Hermes held 2,192 positions worth $43.4B, up 7.8% from $40.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes's Q1 2024 filing shows 164 new, 795 increased, 936 reduced and 172 closed positions. Its largest new stake was Kanzhun: 4,861,533 shares worth $85.2M. The largest sale was Medtronic, an estimated $189M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
- Federated Hermes's largest Q1 2024 buy was Kanzhun: 4,861,533 shares worth $85.2M.
- Federated Hermes added most to Bristol-Myers Squibb in Q1 2024, an estimated $193M increase.
- Federated Hermes's biggest Q1 2024 reduction was Medtronic, cutting an estimated $189M.
- Federated Hermes fully exited Alteryx Inc in Q1 2024, selling an estimated $94.1M.
- Federated Hermes's ten largest holdings make up 13% of its $43.4B portfolio in Q1 2024.
- Federated Hermes opened 164 new positions and closed 172 in Q1 2024.
- Federated Hermes's portfolio value rose 7.8% quarter-over-quarter to $43.4B.
Based on Federated Hermes's 13F filing for Q1 2024, filed 14 May 2024.